Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00326885
Status:
COMPLETED
Last Update Posted:
2018-10-17
First Post:
2006-05-15
Brief Title:
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
Sponsor:
Neovii Biotech
Organization:
Neovii Biotech
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Malignant Ascites |
Keywords:
| Name | View |
|---|---|
| Peritoneal Neoplasms | View |
| Ascites | View |
| Epithelial Cancer | View |
| Epithelial Carcinoma | View |
| Epithelial Ovarian Cancer | View |
| Epithelial Ovarian Carcinoma | View |
| Fallopian Tube Cancer | View |
| Fallopian Tube Carcinoma | View |
| Malignant Ascites | View |
| Ovarian Cancer | View |
| Ovarian Carcinoma | View |
| Ovarian Epithelial Cancer | View |
| Ovarian Epithelial Carcinoma | View |
| Peritoneal Cancer | View |
| Peritoneal Carcinoma | View |
| Recurrent Ascites | View |
| Recurrent Malignant Ascites | View |
| Recurrent Symptomatic Malignant Ascites | View |
| Symptomatic Malignant Ascites | View |
| Symptomatic Ascites | View |
| Neoplasms Glandular and Epithelial | View |
| Ovarian Neoplasms | View |
| Fallopian Tube Neoplasms | View |